SCHEMBL1760877

SCHEMBL1760877

COc1ncnc2sc(NC(=O)N3CCC(N)C3)nc12

nearest known ligand 0.42

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 11/20 0.42
ADORA1 P30542 9/20 0.42
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HDAC1 Q13547 1/20 0.37
HDAC2 Q92769 1/20 0.37
JAK2 O60674 1/20 0.37
JAK3 P52333 1/20 0.37
PIK3CD O00329 5/20 0.37
PIK3CA P42336 5/20 0.37
ADORA3 P0DMS8 2/20 0.35
ADORA2B P29275 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12592880 1.00 ADORA2A (0.42) ADORA2AADORA1ALDH1A1MAPTTSHR
SCHEMBL1760963 1.00 ADORA2A (0.42) ADORA2AADORA1ALDH1A1MAPTTSHR
SCHEMBL1760991 0.94 ADORA2A (0.46) ADORA2AADORA1ALDH1A1MAPTTSHR
SCHEMBL4050561 0.85 PIK3CD (0.41) ADORA2AADORA1PIK3CDPIK3CA
SCHEMBL4049256 0.85 PIK3CD (0.41) ADORA2AADORA1PIK3CDPIK3CA
SCHEMBL13176908 0.84 ADORA2A (0.48) ADORA2AADORA1PIK3CDPIK3CAADORA3
SCHEMBL4052091 0.83 ADORA2A (0.43) ADORA2AADORA1ALDH1A1MAPTTSHR
SCHEMBL4049475 0.83 ADORA2A (0.42) ADORA2AADORA1ALDH1A1MAPTTSHR
SCHEMBL1760842 0.83 ADORA2A (0.50) ADORA2AADORA1ALDH1A1MAPTTSHR
SCHEMBL12592956 0.83 ADORA2A (0.50) ADORA2AADORA1ALDH1A1MAPTTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7947692-B2 Substituted thiazolo[5,4-d]pyrimidine urea derivatives HOFFMANN-LA ROCHE INC. (US) 2011-05-24 US disclosed
WO-2007134958-A1 THIAZOLO-PYRAMIDINE / PYRIDINE UREA DERIVATIVES AS ADENOSINE A2B RECEPTOR ANTAGONISTS F. HOFFMANN-LA ROCHE AG (CH) 2007-11-29 WO disclosed